re: poor shareholders Today's low formed a double bottom. This should be a solid base to go higher once news of the pre-clinical immunity trials and the continuous infusion results are known and further to when the phase II cancer trials will start. Let's hope the worst is behind us...
SBP
solbec pharmaceuticals limited
